Long‐term tolerance to factor VIII is achieved by administration of interleukin‐2/interleukin‐2 monoclonal antibody complexes and low dosages of factor VIII
| Autor: | Liu, C.L., Ye, P., Lin, J., Djukovic, D., Miao, C.H. * |
|---|---|
| Zdroj: | In Journal of Thrombosis and Haemostasis June 2014 12(6):921-931 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Plný text